Quick facts from the U.S. Census Bureau. quickfacts.census.gov/qfd/states/00000.html. 2011 January 8.
2.
National Institutes of Health guidelines on the inclusion of women and minorities as subjects in clinical research. Fed Register, 1994; 59:14508–14513.
3.
PinnVW, RothC, BatesAC, WagnerR, JaremaK. Monitoring adherence to the NIH policy on the inclusion of women and minorities as subjects in clinical research. orwh.od.nih.gov/inclusion/2009AnnualTrackingInclusionComprehensiveRpt.pdf. 2010 January 8.
4.
Institute of Medicine. Women's health research: Progress, pitfalls, and promise. Washington, DC: National Academies Press, 2010.
5.
HarrisDJ, DouglasPS. Enrollment of women in cardiovascular clinical trials funded by the National Heart, Lung, and Blood Institute. N Engl J Med, 2000; 343:475–480.
6.
MelloniC, BergerJS, WangTYet al.Representation of women in randomized clinical trials of cardiovascular disease prevention. Circ CVardiovasc Qual Outcomes, 2010; 3:135–142.
7.
SullivanPS, McNaghtenAD, BegleyE, HutchinsonA, CargillVA. Enrollment of racial/ethnic minorities and women with HIV in clinical research studies of HIV medicines. J Natl Med Assoc, 2007; 99:242–250.
8.
HeiatA, GrossCP, KrumholzHM. Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med, 2002; 62:1682–1688.
9.
MurthyVH, KrumholzHM, GrossCP. Participation in cancer clinical trials: Race-, sex-, and age-based disparities. JAMA, 2004; 291:2720–2726.
10.
JagsiR, SheetsN, JankovicA, MotomuraAR, AmarnathS, UbelPA. Underrepresentation of women in high-impact published clinical cancer research. Cancer, 2009; 115:3293–3301.
11.
BlauwetLA, HayesSN, McManusD, RedbergRF, WalshMN. Low rate of sex-specific result reporting in cardiovascular trials. Mayo Clin Proc, 2007; 82:166–170.
12.
Corbie-SmithG, St GeorgeDM, Moody-AyersS, RansohoffDF. Adequacy of reporting race/ethnicity in clinical trials in areas of health disparities. J Clin Epidemiol, 2003; 56:416–420.
13.
GellerSE, KochP, PellettieriB, CarnesM. Inclusion, analysis, and reporting of sex and race/ethnicity in clinical trials: Have we made progress?J Womens Health, 2011; 20:315–320.
14.
GellerSE, AdamsMG, CarnesM. Aherence to federal guidelines for reporting of sex and race/ethnicity in clinical trials. J Womens Health, 2005; 1123–1131.
15.
BurkeJF, BrownDL, LisabethLD, SanchezBN, MorgensternLB. Enrollment of women and minorities in NINDS trials. Neurology, 2011January5[Epub ahead of print]
